CNQ : BETR.CN

BetterLife Pharma Inc.

$0.22 CAD

$0.01 (2.33%)

Volume
25.05K
Average Volume
231.74K
Market Capitalization
$35.62M
P/E Ratio
-17.60
Dividend Yield
0.00%
Price Target
Year High
$0.25
Year Low
$0.04
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.04
Company Overview

CNQ

Ahmad Doroudian

Biotechnology

Healthcare

BETR.CN

4

CA

CAD

https://www.abetterlifepharma.com

778 997 1928

08772P202

N/A

Liquidity Metrics

-0.11

0.04

0.04

0.00

0.00

Sales & Valuation

-$

0.00

-3.49

-41.88

-0.01

Profitability

-$0.0102

-$1.5M

0.00%

0.00%

19.88%

-780.97%

P/E Metrics

-17.60

0.13

0.13

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Company Executives
Name Title
Hooshmand Sheshbaradaran Chief Operating Officer
Ahmad Doroudian Founder, CEO & Director
Stephen Sangha Corporate Development Advisor & Director
Scott Rudge Head of CMC
Douglas L. Drysdale Executive Chairman & Member of Scientific Advisory Board
Moira Ong Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About BetterLife Pharma Inc. (CNQ:BETR.CN) Stock

BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary interferon-based technologies, designed to engage the immune system in combating viral infections. Its active development pipeline includes BETR-001, intended for major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder. Another key asset, BETR-002, is being advanced to address benzodiazepine dependency, anxiety, and spasticity. Further in development are MM-003 for COVID-19 and other respiratory viral infections; MM-001, a topical intravaginal cream for HPV-induced cervical intraepithelial neoplasia; ... and AP-002, designated for cancer treatment. BetterLife Pharma Inc. maintains a research collaboration with the University of California San Diego, focusing on preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. Headquartered in Vancouver, Canada, the company was founded in 2002 and was formerly known as Pivot Pharmaceuticals Inc. before adopting the name BetterLife Pharma Inc. in December 2019.

BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing

2026-06-22 08:00:00

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced

BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director

2026-05-13 08:00:00

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the

Frequently Asked Questions

What is the current BetterLife Pharma Inc. (BETR.CN) stock price?

BetterLife Pharma Inc.(CNQ:BETR.CN) stock price is $0.22 in the last trading session. During the trading session, BETR.CN stock reached the peak price of $0.25 while $0.04 was the lowest point it dropped to. The percentage change in BETR.CN stock occurred in the recent session was 2.33% while the dollar amount for the price change in BETR.CN stock was $0.01.

BETR.CN's industry and sector of operation?

The CNQ listed BETR.CN is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of BETR.CN?

Hooshmand Sheshbaradaran | Chief Operating Officer
Ahmad Doroudian | Founder, CEO & Director
Stephen Sangha | Corporate Development Advisor & Director
Scott Rudge | Head of CMC
Douglas L. Drysdale | Executive Chairman & Member of Scientific Advisory Board

How many employees does BETR.CN have?

Number of BETR.CN employees currently stands at 4. BETR.CN operates from 1275 West 6th Avenue, Vancouver, BC V6H 1A6, CA.

Link for BETR.CN official website?

Official Website of BETR.CN is: https://www.abetterlifepharma.com

How do I contact BETR.CN?

BETR.CN could be contacted at phone #778 997 1928 and can also be accessed through its website. BETR.CN operates from 1275 West 6th Avenue, Vancouver, BC V6H 1A6, CA.

How many shares of BETR.CN are traded daily?

The average number of BETR.CN shares traded daily for last 3 months was 231.74K.

What is the market cap of BETR.CN currently?

The market value of BETR.CN currently stands at $35.62M with its latest stock price at $0.22